255 related articles for article (PubMed ID: 33726742)
21. What's new in the treatment of portopulmonary hypertension?
DuBrock HM; Channick RN; Krowka MJ
Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):983-92. PubMed ID: 25882070
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up of portopulmonary hypertension patients after liver transplantation.
Khaderi S; Khan R; Safdar Z; Stribling R; Vierling JM; Goss JA; Sussman NL
Liver Transpl; 2014 Jun; 20(6):724-7. PubMed ID: 24648168
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease.
Savale L; Manes A
Eur Heart J Suppl; 2019 Dec; 21(Suppl K):K37-K45. PubMed ID: 31857799
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
Savale L; Sattler C; Coilly A; Conti F; Renard S; Francoz C; Bouvaist H; Feray C; Borentain P; Jaïs X; Montani D; Parent F; O'Connell C; Hervé P; Humbert M; Simonneau G; Samuel D; Calmus Y; Duvoux C; Durand F; Duclos-Vallée JC; Sitbon O
Hepatology; 2017 May; 65(5):1683-1692. PubMed ID: 27997987
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg.
DuBrock HM; Runo JR; Sadd CJ; Burger CD; Cartin-Ceba R; Rosen CB; Taner T; Nyberg SL; Heimbach JK; Findlay JY; Krowka MJ
Transplant Direct; 2020 Dec; 6(12):e630. PubMed ID: 33204828
[TBL] [Abstract][Full Text] [Related]
26. [Pulmonary hypertension in liver diseases].
Savale L; Sattler C; Sitbon O
Presse Med; 2014 Sep; 43(9):970-80. PubMed ID: 25148949
[TBL] [Abstract][Full Text] [Related]
27. Predictors of survival in portopulmonary hypertension: a 20-year experience.
Aggarwal M; Li M; Bhardwaj A; Wallace WD; Wang X; Carey WD; Dweik RA; Heresi GA; Tonelli AR
Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):449-456. PubMed ID: 34907982
[TBL] [Abstract][Full Text] [Related]
28. [Porto-pulmonary hypertension].
Chabot F; Gomez E; Boyer L; Kheir A; Le Pavec J; Sitbon O; Herve P
Rev Mal Respir; 2006 Dec; 23(6):629-41. PubMed ID: 17202968
[TBL] [Abstract][Full Text] [Related]
29. Current management approaches to portopulmonary hypertension.
Savale L; O'Callaghan DS; Magnier R; Le Pavec J; Hervé P; Jaïs X; Seferian A; Humbert M; Simonneau G; Sitbon O
Int J Clin Pract Suppl; 2011 Jan; (169):11-8. PubMed ID: 21176011
[TBL] [Abstract][Full Text] [Related]
30. Vasomodulators and Liver Transplantation for Portopulmonary Hypertension: Evidence From a Systematic Review and Meta-Analysis.
Deroo R; Trépo E; Holvoet T; De Pauw M; Geerts A; Verhelst X; Colle I; Van Vlierberghe H; Fallon MB; Raevens S
Hepatology; 2020 Nov; 72(5):1701-1716. PubMed ID: 32017176
[TBL] [Abstract][Full Text] [Related]
31. Current clinical understanding and effectiveness of portopulmonary hypertension treatment.
Tamura Y; Tamura Y; Taniguchi Y; Atsukawa M
Front Med (Lausanne); 2023; 10():1142836. PubMed ID: 37081835
[TBL] [Abstract][Full Text] [Related]
32. Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension.
Chiva T; Ripoll C; Sarnago F; Rincón D; Gómez-Camarero J; Galindo E; Catalina MV; Elizaga J; Bañares R
Liver Int; 2015 Feb; 35(2):353-61. PubMed ID: 24797536
[TBL] [Abstract][Full Text] [Related]
33. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Portopulmonary hypertension.
Saleemi S; Idrees MM
Ann Thorac Med; 2014 Jul; 9(Suppl 1):S42-6. PubMed ID: 25076996
[TBL] [Abstract][Full Text] [Related]
34. Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry.
Tamura Y; Tamura Y; Taniguchi Y; Tsujino I; Inami T; Matsubara H; Shigeta A; Sugiyama Y; Adachi S; Abe K; Baba Y; Hatano M; Ikeda S; Kusunose K; Sugimura K; Usui S; Takeishi Y; Dohi K; Hasegawa-Tamba S; Horimoto K; Kikuchi N; Kumamaru H; Tatsumi K;
Circ Rep; 2022 Nov; 4(11):542-549. PubMed ID: 36408361
[No Abstract] [Full Text] [Related]
35. [Liver diseases and pulmonary vascular disorders].
Riou M; Jutant EM; Mignard X; Canuet M; Humbert M; Sitbon O; Savale L; Montani D
Rev Med Interne; 2018 Dec; 39(12):925-934. PubMed ID: 30174113
[TBL] [Abstract][Full Text] [Related]
36. Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study.
Jose A; Rahman N; Opotowsky AR; Glorioso TJ; Waldo SW; Zeder K; Seto A; Elwing JM; McCormack FX; Maron BA
J Am Heart Assoc; 2024 Apr; 13(8):e033847. PubMed ID: 38567662
[TBL] [Abstract][Full Text] [Related]
37. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
[TBL] [Abstract][Full Text] [Related]
38. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension.
Cartin-Ceba R; Burger C; Swanson K; Vargas H; Aqel B; Keaveny AP; Heimbach J; Taner T; Nyberg S; Rosen C; Cajigas H; DuBrock H; Krowka MJ
Transplantation; 2021 Oct; 105(10):2283-2290. PubMed ID: 33065725
[TBL] [Abstract][Full Text] [Related]
39. Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview.
Porres-Aguilar M; Altamirano JT; Torre-Delgadillo A; Charlton MR; Duarte-Rojo A
Eur Respir Rev; 2012 Sep; 21(125):223-33. PubMed ID: 22941887
[TBL] [Abstract][Full Text] [Related]
40. Treatment Barriers in Portopulmonary Hypertension.
AbuHalimeh B; Krowka MJ; Tonelli AR
Hepatology; 2019 Jan; 69(1):431-443. PubMed ID: 30063259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
